CIMPASI-1 and -2 show certolizumab pegol benefits patients with severe plaque psoriasisMarch 5, 2017PsoriasisPsoriatic Arthritis
Perioperative infliximab does not increase serious infection riskFebruary 6, 2017PsoriasisPsoriatic Arthritis
VIDEO: Interchangeability of biosimilars and parent compounds raise potential efficacy issuesJanuary 29, 2017PsoriasisPsoriatic Arthritis
FDA opens abbreviated approval pathway for interchangeable biosimilarsJanuary 26, 2017PsoriasisPsoriatic Arthritis
Bone fractures more likely to occur in psoriasis, PsA patientsJanuary 24, 2017Psoriatic ArthritisPsoriasis
Medicare payments set for infliximab biosimilar InflectraJanuary 10, 2017Psoriatic ArthritisPsoriasis
Initial suboptimal responders to secukinumab usually bloom laterDecember 21, 2016PsoriasisPsoriatic Arthritis
Ixekizumab proves highly effective for palmoplantar, scalp psoriasisDecember 21, 2016PsoriasisPsoriatic Arthritis
